MENU
CCCC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
C4 Therapeutics (CCCC) Ownership - Who owns C4 Therapeutics?
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives... Show more
Profile
Industry
N/A
Address
490 Arsenal Way
Phone
+1 617 231-0700
Employees
145
Web
https://www.c4therapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
142.72M
P/E Ratio
N/A
Total Cash
215.09M
Projected Growth
N/A
Total Debt
64.37M
Revenue
39.78M
Risk (Beta)
3.53
Dividend Yield
N/A
Total Cash/Share
3.03
Total Debt/Equity
N/A
Revenue/Share
0.57 USD as % of share price
Fundamentals
CCCC
Capitalization
143M
P/E Ratio
N/A
Risk (Beta)
3.53
Dividend Yield
N/A
Total Cash
215M
Total Cash/Share
3.03
Total Debt
64.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.57%
Revenue
39.8M
ROE
N/A
Book Value
195M
P/B Ratio
0.76
Cash Flow
N/A
Earnings
-1.48
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7K
Current Ratio
5.70
Current Revenue Per Employee
65800.00
Dividends Per Share - Security
N/A
EBITDA
-102.74M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-28.77
Shares Held By Institutions
114M
Shares Outstanding - Current
71M
Total Liabilities
124M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-41.667
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
490 Arsenal Way
Phone
+1 617 231-0700
Employees
145
Web
https://www.c4therapeutics.com